arrow
Ó

Óscar Sotolongo-Grau

ace alzheimer center barcelona and universitat internacional de catalunya
H指数:30
被引数:6,027

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A peripheral proteomic signature of Alzheimer’s disease is identified in the plasma extracellular vesicles of mild cognitive impairment patients from a memory clinic: the BIOPEXAL study

阿尔茨海默病的外周蛋白质组学特征在记忆诊所轻度认知障碍患者的血浆外泌体中被鉴定:BIOPEXAL研究

2026-09-100
OA
Plasma Aβ42/Aβ40 predicts longitudinal amyloid pathology and clinical progression in amyloid-PET negative individuals with subjective cognitive decline

血浆Aβ42/Aβ40预测主观认知下降且淀粉样蛋白-PET阴性的个体的纵向淀粉样蛋白病理和临床进展

2026-09-100
OA
Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI study

基线淀粉样蛋白PET的量化可以在主观认知下降个体中识别淀粉样蛋白积累和认知恶化的风险:FACEHBI研究

2025-04-230
OA
Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO
2025-03-250
OAAI
Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort

tau PET示踪剂 [18F]PI-2620和 [18F]RO948在患有脑淀粉样蛋白沉积的非痴呆个体中的头对头比较: TAU-PET FACEHBI队列

2024-11-280
OAAI
Clinical value of plasma pTau181 to predict Alzheimer's ' s disease pathology in a large real-world cohort of a memory clinic

血浆pTau181在记忆诊所大型真实队列中预测阿尔茨海默病病理的临床价值

2024-10-010
OAAI
An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response

SIRPβ1内的插入显示出对阿尔茨海默氏病认知下降的双重作用,改变了小胶质细胞的反应

2024-03-191
PRE
Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort
2024-02-203
OAAI
Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment
2023-02-1410
OAAI
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (vol 12, 3417, 2021)

阿尔茨海默病的常见变异和多基因风险评分的风险分层 (第12卷,3417,2021)

2023-02-090
OAAI
New insights into the genetic etiology of Alzheimer's disease and related dementias

对阿尔茨海默氏病和相关痴呆症的遗传病因的新见解

2022-04-04919
OAAI
Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort
2022-03-1810
OAAI
Genomic Characterization of Host Factors Related to SARS-CoV-2 Infection in People with Dementia and Control Populations: The GR@ACE/DEGESCO Study
2021-12-075
OAAI
BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols
2021-09-289
OAAI
Combination of white matter hyperintensities and Aβ burden is related to cognitive composites domain scores in subjective cognitive decline: the FACEHBI cohort
2021-08-177
OAAI
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

阿尔茨海默病的常见变异和多基因风险评分的风险分层

2021-06-07160
OAAI
Early detection of amyloid load using 18F-florbetaben PET
2021-03-2739
OAAI
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study

血浆Aβ42/40比值单独或联合fdg-pet可准确预测淀粉样蛋白-PET阳性: 来自AB255研究的横断面分析

2019-12-0146
OAAI
Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

痴呆及其临床内表型的全基因组关联分析揭示了与阿尔茨海默病相关的新基因座和三个因果关系网络: GR @ ACE项目

2019-08-28108
OAAI
Whole exome sequencing analysis reveals TRPV3 as a risk factor for cardioembolic stroke
2018-03-096
PREAI